The experimental protocol for the in vivo study is shown in Figure 6A. Since Rh2 demonstrated the radiosensitization effect in an in vitro study, we further examined the therapeutic efficacy in a CT26/luc tumor-bearing animal model. The gene discussed is RHAG; the disease is neoplasm.